News for 'Drug Administration'

Wockhardt hit by FDA alert on another plant

Wockhardt hit by FDA alert on another plant

Rediff.com27 Nov 2013

Its factory in Chikalthana in western India was last month hit by the British drug regulator's curb on imports from the plant over manufacturing deficiencies.

Ranbaxy gets USFDA nod for Atenolol tabs

Ranbaxy gets USFDA nod for Atenolol tabs

Rediff.com2 Jan 2007

Ranbaxy Pharmaceuticals Inc said on Tuesday it has received US Food and Drug Administration's approval for manufacturing and marketing cardiovascular drug -- Atenolol tablets in the US.

Johnson & Johnson allowed to manufacture and sell baby powder

Johnson & Johnson allowed to manufacture and sell baby powder

Rediff.com11 Jan 2023

The Bombay high court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license and asking it to stop the product manufacture and sale, terming them as "stringent, unreasonable and unfair". A division bench of Justices Gautam Patel and S G Dige also came down heavily on the state Food and Drug Administration (FDA) for its delay in carrying out tests on a sample of the company's baby powder seized in December 2018. The bench noted that while maintaining standards of quality and safety are of utmost importance for cosmetic products, at the same time it does not seem reasonable to shut down the whole manufacturing process when there is a slight deviation in one of the products.

It's a tough road ahead for pharma companies

It's a tough road ahead for pharma companies

Rediff.com29 May 2013

Post Ranbaxy episode, domestic pharma companies may face frequent inspections and deeper scrutiny.

Wockhardt staring at a crisis?

Wockhardt staring at a crisis?

Rediff.com25 May 2013

Wockhardt might be headed for another crisis, as it has come under the scanner of US health regulator.

Apex drug body wants ban on 1,105 brands

Apex drug body wants ban on 1,105 brands

Rediff.com23 Jun 2007

These brands belong to about 320 drugs of leading Indian pharmaceutical companies. The Drug Controller General of India's (DCGI's) office feels that these have been launched without its approval.

Where to buy medicines during Mumbai's chemists strike

Where to buy medicines during Mumbai's chemists strike

Rediff.com14 Oct 2012

The Maharashtra State Chemists and Druggists Association has called for a three-day token strike from October 16-18, to protest alleged harassment by the Food and Drugs Administration officials.

Ranbaxy gets USFDA nod for Dispermox

Ranbaxy gets USFDA nod for Dispermox

Rediff.com14 Aug 2003

Ranbaxy Laboratories, in a release issued to the BSE on Thursday, said the US Food and Drug Administration has granted the company permission to market DisperMox (amoxicillin tablets for oral suspension - 200mg and 400mg).\n\n

Ranbaxy gets US nod for Ofloxacin

Ranbaxy gets US nod for Ofloxacin

Rediff.com3 Sep 2003

Indian drug major Ranbaxy Laboratories has got the US Food and Drug Administration nod for the manufacture and sale of Ofloxacin tablets.

Ranbaxy gets FDA nod for Loratidine

Ranbaxy gets FDA nod for Loratidine

Rediff.com21 Aug 2003

Ranbaxy Laboratories on Thursday said it had received Abbreviated New Drug Application approval from the US Food and Drug Administration to manufacture and market Loratidine

Dr Reddy's files second NDA in US

Dr Reddy's files second NDA in US

Rediff.com27 Jun 2003

Ranbaxy gets US nod for Glimepiride

Ranbaxy gets US nod for Glimepiride

Rediff.com7 Oct 2005

Ranbaxy Laboratories Ltd on Friday said it has received approval from the US Food and Drug Administration to manufacture and market multiple dosages of anti-diabetes drug Glimepiride tablets.

Wockhardt gets FDA nod to market painkillers in US

Wockhardt gets FDA nod to market painkillers in US

Rediff.com20 Mar 2007

Wockhardt Ltd said on Tuesday it has got US Food and Drug Administration's approval to market painkiller tablets containing a combination of Dextropropoxyphene napsylate and Acetaminophen in the US market.

US withdraws emergency use of hydroxychloroquine for Covid-19

US withdraws emergency use of hydroxychloroquine for Covid-19

Rediff.com15 Jun 2020

The Food and Drug Administration said its decision is based on new information, including clinical trial data results, that have led it to conclude that the drugs may not be effective to treat COVID-19 and that its potential benefits for such use do not outweigh its known and potential risks.

Are Punjabi pop songs promoting its drug culture?

Are Punjabi pop songs promoting its drug culture?

Rediff.com9 Jun 2016

'Almost 60 per cent of 2,000 songs had references to drugs and violence.'

Aventis sues Dr Reddy's

Aventis sues Dr Reddy's

Rediff.com27 Mar 2003

Damning drug report fuels anger in Australia

Damning drug report fuels anger in Australia

Rediff.com9 Feb 2013

Australian sports administrators responded angrily to a government report saying doping was widespread among professional and amateur athletes and demanded investigators name offenders to protect clean athletes' reputations.

Singapore could be possible site for Ranbaxy arbitration

Singapore could be possible site for Ranbaxy arbitration

Rediff.com3 Jun 2013

The 2008 deal agreement contains provisions of arbitration to be held in that country.

Mice, roaches found in food served on US airlines: FDA

Mice, roaches found in food served on US airlines: FDA

Rediff.com21 Nov 2012

In a shocker, the US Food and Drug Administration has discovered the presence of mice, ants and cockroaches in food served on airlines in the country.

Mice, roaches found in food served on US airlines

Mice, roaches found in food served on US airlines

Rediff.com21 Nov 2012

Through a Freedom of Information Act request, the Show '20/20' obtained lists of recent health violation records from the FDA, the agency in charge of inspecting airlines and their outside food caterers.

Malvinder Singh on Ranbaxy's setback

Malvinder Singh on Ranbaxy's setback

Rediff.com17 Jul 2008

All medicines that have USFDA approvals continue to be produced in the Poanta Sahib facility. The USFDA has not given any approval for new drugs as they have some concerns. We are addressing them, Malvinder Singh said.

NRI's energy drink under scanner for 13 deaths in US

NRI's energy drink under scanner for 13 deaths in US

Rediff.com16 Nov 2012

A popular energy drink, produced by a company founded by an Indian-American billionaire, has come under the scanner in the United States after reports of 13 deaths possibly linked to the energy shots.

Hydroxychloroquine can be fatal: Experts

Hydroxychloroquine can be fatal: Experts

Rediff.com6 May 2020

As the pandemic spreads and the urgency for effective treatment of COVID-19 mounts, several countries, including the US, have started relying heavily on HCQ, majorly used in the treatment of malaria and rheumatoid-arthritis.

FDA asks Wockhardt to conduct global assessment of its plants

FDA asks Wockhardt to conduct global assessment of its plants

Rediff.com4 Dec 2013

The FDA Commissioner Margaret Hamburg is slated to travel to India soon.

Wockhardt to launch new antibiotic in US next week

Wockhardt to launch new antibiotic in US next week

Rediff.com2 Jun 2006

The company has already received approval from the US Food & Drug Administration for marketing clarithromycin tablets.

Imitrex delay: Ranbaxy may lose up to Rs 300 cr

Imitrex delay: Ranbaxy may lose up to Rs 300 cr

Rediff.com2 Jan 2009

Drug major Ranbaxy Laboratories could suffer a potential revenue loss to the tune of Rs 300 crore (Rs 3 billion) due to delay in receiving approval from the US Food and Drug Administration (FDA) for generic version of GSK's anti-migraine medicine Imitrex, according to analysts.

No sabotage at Toansa plant, says Ranbaxy

No sabotage at Toansa plant, says Ranbaxy

Rediff.com12 Feb 2014

Company is among the few companies in the sector getting pulled up by FDA for violations at its factories in India.

Reddy's files with US FDA for generic Olanzapine

Reddy's files with US FDA for generic Olanzapine

Rediff.com11 Mar 2003

Drugmaker Dr Reddy's Laboratories has filed an application with the US Food and Drug Administration to market a generic form of Eli Lilly's schizophrenia drug Olanzapine in the US

Dr Reddy's files with US FDA for generic Zofran

Dr Reddy's files with US FDA for generic Zofran

Rediff.com8 May 2003

Indian drugmaker Dr Reddy's Laboratories said on Thursday it had filed an application with the US Food and Drug Administration to market a generic form of GlaxoSmithKline's anti-nausea drug Zofran.\n\n

US allows Ranbaxy to market flecainide acetate

US allows Ranbaxy to market flecainide acetate

Rediff.com1 Apr 2003

In a major boost to Ranbaxy Laboratories' exports to developed countries, the United States has approved marketing of flecainide acetate tablets in the country.

Australia suspends import of Maggi Noodles from India

Australia suspends import of Maggi Noodles from India

Rediff.com15 Jun 2015

Maggi has also come on the radar of US Food and Drug Administration.

Ranbaxy recalls 7.3 cr Gabapentin tablets

Ranbaxy recalls 7.3 cr Gabapentin tablets

Rediff.com16 Nov 2007

In a setback to pharmaceutical major Ranbaxy Laboratories Ltd, the US drug regulator USFDA has directed the company to recall as many as 7.32 crore (73.2 million) Gabapentin tablets of 600 and 800 mg strengths.

Dr Reddy's launches generic Parkinson's disease tablets in US

Dr Reddy's launches generic Parkinson's disease tablets in US

Rediff.com7 Jun 2012

The tablets are bio equivalent generic version of GlaxoSmithKline's Requip XL tablets

Ranbaxy gets FDA nod for Fluconazole tablets

Ranbaxy gets FDA nod for Fluconazole tablets

Rediff.com6 May 2003

Ranbaxy Laboratories has received tentative approval form the Food & Drug Administration USA for manufacturing and marketing Fluconazole tablets

All you want to know about insider trading

All you want to know about insider trading

Rediff.com17 Jun 2008

Insiders who have 'privileged' access to the right information make the gains, while the ordinary investor is left holding overvalued stocks. Here's help to avoid that trap

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Dilip Shanghvi's success: From a start-up to India's largest drug maker

Rediff.com11 Mar 2015

Dilip Shanghvi founded Sun Pharma in 1983.